|
1
|
Zhou Y, Ren H, Dai B, Li J, Shang L, Huang
J and Shi X: Hepatocellular carcinoma-derived exosomal miRNA-21
contributes to tumor progression by converting hepatocyte stellate
cells to cancer-associated fibroblasts. J Exp Clin Cancer Res.
37:3242018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liao ZB, Tan XL, Dong KS, Zhang HW, Chen
XP, Chu L and Zhang BX: miRNA-448 inhibits cell growth by targeting
BCL-2 in hepatocellular carcinoma. Dig Liver Dis. Sep 28–2018.(Epub
ahead of print). View Article : Google Scholar
|
|
3
|
Pei Y, Sun X, Guo X, Yin H, Wang L, Tian
F, Jing H, Liang X, Xu J and Shi P: FGF8 promotes cell
proliferation and resistance to EGFR inhibitors via upregulation of
EGFR in human hepatocellular carcinoma cells. Oncol Rep.
38:2205–2210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Talkowski ME, Maussion G, Crapper L,
Rosenfeld JA, Blumenthal I, Hanscom C, Chiang C, Lindgren A,
Pereira S, Ruderfer D, et al: Disruption of a large intergenic
noncoding RNA in subjects with neurodevelopmental disabilities. Am
J Hum Genet. 91:1128–1134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan Y, Li C, Chen J, Zhang K, Chu X, Wang
R and Chen L: The emerging roles of long noncoding RNA ROR
(lincRNA-ROR) and its possible mechanisms in human cancers. Cell
Physiol Biochem. 40:219–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou P and Sun L, Liu D, Liu C and Sun L:
Long non-coding RNA lincRNA-ROR promotes the progression of colon
cancer and holds prognostic value by associating with miR-145.
Pathol Oncol Res. 22:733–740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dimitrova N, Zamudio JR, Jong RM, Soukup
D, Resnick R, Sarma K, Ward AJ, Raj A, Lee JT, Sharp PA, et al:
LincRNA-p21 activates p21 in cis to promote Polycomb target
gene expression and to enforce the G1/S checkpoint. Mol Cell.
54:777–790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang N, Fu Y, Zhang H, Sima H, Zhu N and
Yang G: LincRNA-p21 activates endoplasmic reticulum stress and
inhibits hepatocellular carcinoma. Oncotarget. 6:28151–28163.
2015.PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, Li X,
Ma Z, Li X and Zhang Y: LincRNA-p21 enhances the sensitivity of
radiotherapy for human colorectal cancer by targeting the
Wnt/β-catenin signaling pathway. Oncol Rep. 31:1839–1845. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang YJ and Bikle DD: LncRNA profiling
reveals new mechanism for VDR protection against skin cancer
formation. J Steroid Biochem Mol Biol. 144:87–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Işın M, Uysaler E, Özgür E, Köseoğlu H,
Şanlı Ö, Yücel ÖB, Gezer U and Dalay N: Exosomal lncRNA-p21 levels
may help to distinguish prostate cancer from benign disease. Front
Genet. 6:1682015.PubMed/NCBI
|
|
14
|
Zhai H, Fesler A, Schee K, Fodstad O,
Flatmark K and Ju J: Clinical significance of long intergenic
noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer.
12:261–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Castellano JJ, Navarro A, Viñolas N,
Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D,
Molins L, et al: LincRNA-p21 impacts prognosis in resected
non-small cell lung cancer patients through angiogenesis
regulation. J Thorac Oncol. 11:2173–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia M, Jiang L, Wang YD, Huang JZ, Yu M
and Xue HZ: lincRNA-p21 inhibits invasion and metastasis of
hepatocellular carcinoma through Notch signaling-induced
epithelial-mesenchymal transition. Hepatol Res. 46:1137–1144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schofield CJ and Ratcliffe PJ: Oxygen
sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 5:343–354.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartrons R and Caro J: Hypoxia, glucose
metabolism and the Warburg's effect. J Bioenerg Biomembr.
39:223–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu J, Liang F, Huang H, Pirttiniemi P and
Yu D: Effects of loading on chondrocyte hypoxia, HIF-1α and VEGF in
the mandibular condylar cartilage of young rats. Orthod Craniofac
Res. 21:41–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dewangan J, Kaushik S, Rath SK and
Balapure AK: Centchroman regulates breast cancer angiogenesis via
inhibition of HIF-1α/VEGFR2 signalling axis. Life Sci. 193:9–19.
2018. View Article : Google Scholar : PubMed/NCBI
|
